6 Real-World Evidence of Safety and Efficacy of Carboplatin plus Nanoparticle Albumin-Bound Paclitaxel in Patients with Advanced Non-Small-Cell Lung Cancer and Preexisting Interstitial Lung Disease: A Retrospective Study

7 Successful management of Mycobacterium abscessus complex lung disease in an otherwise healthy infant

8 Invasive Aspergillus infections in hospitalized patients with chronic lung disease

9 Performance of pyrosequencing versus MALDI-TOF MS in bacteria identification in chronic lung disease.

10 Assessment of interstitial lung disease among black rheumatoid arthritis patients.

11 Inhalation Technique Errors with Metered-Dose Inhalers Among Patients with Obstructive Lung Diseases: A Systematic Review and Meta-Analysis of U.S. Studies.

12 Which Biopsy to Diagnose Interstitial Lung Disease? A Call for Evidence and Unity.

13 Clinical and genetic spectrum of interstitial lung disease in Chinese children associated with surfactant protein C mutations.

14 Epithelial expression of an interstitial lung disease–associated mutation in surfactant protein-C modulates recruitment and activation of key myeloid cell populations in mice

15 Surfactant gene polymorphisms and interstitial lung diseases

16 Diagnostic challenges in interstitial lung diseases using the example of microscopic usual interstitial pneumonia image in a patient with the clinical hypothesis of idiopathic pulmonary fibrosis - a case report.

17 Comparison of lymphocyte immune phenotypes in bronchoalveolar lavage of non-smoking patients with sarcoidosis and other interstitial lung diseases.

18 Pulmonary hypertension due to interstitial lung disease.

19 Abandoning developmental silos: what can paediatricians and adult interstitial lung disease physicians learn from each other?

20 Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.

21 Spectrum of interstitial lung diseases at a tertiary center in a developing country: A study of 803 subjects.

22 Transbronchial cryobiopsy in diffuse parenchymal lung disease

23 The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases.

24 Report on the meeting of the working groups on "Nonspecific Lung Diseases" and "Pathophysiology of Breathing" of the Society of Bronchopneumonology and Tuberculosis and the Society of Pathological and Clinical Physiology of the GDR. Berlin, 4 December 1984. Abstracts

25 Endotyping of progressive fibrotic interstitial lung diseases: It is the final destination that matters and not the journey

26 Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): Study protocol

27 Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial

28 Autoantibodies and interstitial lung disease in rheumatoid arthritis: towards a 'mix-and-match' approach?

29 the pronounced high expression of discoidin domain receptor 2 in human interstitial lung diseases

30 surgical treatment of lung cancer combined with interstitial lung disease

31 analysis of chest computed tomography manifestations of non-mycobacterium tuberculosis induced granulomatous lung diseases

32 lung-dominant connective tissue disease among patients with interstitial lung disease: prevalence, functional stability, and common extrathoracic features

33 high-resolution computerized tomography changes in diffuse parenchymal lung disease from chronic hypersensitivity pneumonitis related to bird antigen

34 possibility of interstitial lung disease as a phlebosclerotic colitis manifestation

35 treatment for mycobacterium avium complex lung disease

36 use of clinical characteristics to predict spirometric classification of obstructive lung disease

37 interstitial lung diseases in saudi arabia: a single-center study

38 mechanisms of physical activity limitation in chronic lung diseases

39 cystic lung disease in down syndrome: a case report and literature review

40 serum interleukin-6, interleukin-17a, and transforming growth factor beta are raised in systemic sclerosis with interstitial lung disease

41 cytology of bronchoalveolar lavage fluid in the interstitial lung diseases

42 the clinical utility of lung clearance index in early cystic fibrosis lung disease is not impacted by the number of multiple-breath washout trials

43 modeling using clinical examination indicators predicts interstitial lung disease among patients with rheumatoid arthritis

44 a case report of the presence with diffuse interstitial lung disease

45 establishment of a rat adjuvant arthritis-interstitial lung disease model

46 genetic influences on cystic fibrosis lung disease severity

47 bridge to diagnosis: the use of extracorporeal membrane oxygenation in a child with interstitial lung disease secondary to clinically amyopathic dermatomyositis

48 evaluation of clinical presentation and outcome of patients with respiratory bronchiolitis-associated interstitial lung disease

49 reversible interstitial lung disease with prolonged use of nitrofurantoin: do the benefits outweigh the risks?

50 collagenolytic matrix metalloproteinases in chronic obstructive lung disease and cancer

51 analysis of erythrocyte glycophorin-a variants by flow cytometry in lung disease patients detects the effect of tobacco smoke

52 study the level of sputum matrix metalloproteinase-9 and tissue inhibitor metaloprotienase-1 in patients with interstitial lung diseases

53 lung cancer and interstitial lung diseases: a systematic review

54 doença pulmonar intersticial associada a bronquiolite respiratória respiratory bronchilitis-associated interstitial lung disease

55 celularidade do líquido de lba em crianças e adolescentes saudáveis e com doenças pulmonares cell profile of bal fluid in children and adolescents with and without lung disease

56 vitamin d deficiency and chronic lung disease

57 nets and cf lung disease: current status and future prospects

58 the role of transbronchial biopsy in the diagnosis of diffuse parenchymal lung diseases: con

59 bronchopulmonary dysplasia: chronic lung disease of infancy and long-term pulmonary outcomes

60 hiv and bullous lung disease

61 emerging pparγ-independent role of pparγ ligands in lung diseases

62 Radiomics in Lung Diseases Imaging: State-of-the-Art for Clinicians

63 New insights into lung diseases using hyperpolarized gas MRI

64 A Convolutional Neural Network Approach to Quantify Lung Disease Progression in Patients with Fibrotic Hypersensitivity Pneumonitis (HP).

65 Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis.

66 Diagnosis of Interstitial Lung Disease Caused by Possible Hypersensitivity Pneumonitis in a Child: Think CGD.

Keyword Connections

Journals

Research Groups

Bibliographies